Synapse Medicine: Difference between revisions
Added business details: founded 2017, funding $28M+ |
Added cross-references: AIDAVA Competitive Analysis, AIDAVA Related Companies, Lifen |
||
| Line 24: | Line 24: | ||
== See Also == | == See Also == | ||
* [[AIDAVA Competitive Analysis]] | |||
* [[AIDAVA Related Companies]] | |||
* [[Lifen]] | |||
* [[France]] | * [[France]] | ||
* [[Digital Prescription]] | * [[Digital Prescription]] | ||
Latest revision as of 17:57, 14 April 2026
What They Do[edit]
Digital prescription and medication management platform helping healthcare professionals prescribe safely and manage drug interactions.
Funding[edit]
Valuation: Series B+; est. ~€50-100M Series B+. Backed by BPI France, Elaia Partners.
Business Details[edit]
- Founded: 2017
- Total Funding: $28M+
- Valuation: ~€50-100M (est.)
- Revenue: N/A (private)
- Employees: ~50-80 (est.)
- Key Milestones: $28M raised (TechCrunch reported). Medication intelligence platform. E-prescription safety.